Self-reported quality of life in users and nonusers of dietary supplements in cancer

Supportive Care in Cancer

Volumn 14, Issue 2, 2006, Pages 193-199

  Lis, Christopher G ^a   Cambron, Jerrilyn A ^a   Grutsch, James F ^a   Granick, Joel ^a   Gupta, Digant ^a  

^a CANCER TREATMENT CENTERS OF AMERICA   (United States)

Author keywords

Cancer; Dietary supplements; Quality of life

Indexed keywords

ALTERNATIVE MEDICINE; ANOREXIA; ARTICLE; BREAST CANCER; CANCER; COLORECTAL CANCER; CONSTIPATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; EMOTION; FATIGUE; FEMALE; HEALTH SURVEY; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAUSEA; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SELF REPORT; STATISTICAL SIGNIFICANCE; SYMPTOM; UNIVARIATE ANALYSIS;

ADULT; APPETITE; CONSTIPATION; DIETARY SUPPLEMENTS; EMOTIONS; FATIGUE; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; NAUSEA; NEOPLASMS; QUALITY OF LIFE;

EID: 31044449173     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-005-0876-6     Document Type: Article

References (29)

1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328(4):246-252
2. Eisenberg DM, Davis RB, Ettner SL et al (1998) Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280(18):1569-1575
3. Kessler RC, Davis RB, Foster DF et al (2001) Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 135(4):262-268
4. Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83(4):777-782
5. Boon H, Stewart M, Kennard MA et al (2000) Use of complementary/ alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18(13):2515-2521
6. Correa-Velez I, Clavarino A, Barnett AG, Eastwood H (2003) Use of complementary and alternative medicine and quality of life: changes at the end of life. Palliat Med 17(8):695-703
7. Patterson RE, Neuhouser ML, Hedderson MM et al (2002) Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 8(4):477-485
8. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18(13):2505-2514
9. Gupta D, Lis CG, Birdsall TC, Grutsch JF (2005) The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer 2005 April 23. DOI 10.1007/s00520-005-0820-9
10. Henderson JW, Donatelle RJ (2004) Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altem Ther Health Med 10(1):52-57
11. McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK (2004) Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 12(6):454-462
12. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376
13. Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50(4):441-450
14. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 13(5):1249-1254
15. Ferrans CE, Powers MJ (1985) Quality of life index: development and psychometric properties. J Clin Epidemiol 8(1):15-24
16. Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17(3 Suppl):15-19
17. Ferrans CE, Powers MJ (1992) Psychometric assessment of the Quality of Life Index. Res Nurs Health 15(1):29-38
18. Ferrans CE (1996) Development of a conceptual model of quality of life. Sch Inq Nurs Pract 10(3):293-304
19. Warnecke RB, Ferrans CE, Johnson TP et al (1996) Measuring quality of life in culturally diverse populations. J Natl Cancer Inst Monogr (20):29-38
20. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340 (22):1733-1739
21. Cassileth BR, Lusk EJ, Guerry D et al (1991) Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 324(17):1180-1185
22. Paltiel O, Avitzour M, Peretz T et al (2001) Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 19(9):2439-2448
23. Bliley AV, Ferrans CE (1993) Quality of life after coronary angioplasty. Heart Lung 22(3):193-199
24. Johnson CD, Wicks MN, Milstead J, Hartwig M, Hathaway DK (1998) Racial and gender differences in quality of life following kidney transplantation. Image J Nurs Scholarsh 30(2):125-130
25. Panel on Definition and Description (1997) Defining and describing complementary and alternative medicine. CAM Research Methodology Conference, April 1995. Altern Ther Health Med 3(2):49-57
26. Chatwin J, Tovey P (2004) Complementary and alternative medicine (CAM), cancer and group-based action: a critical review of the literature. Eur J Cancer Care (Engl) 13(3):210-218
27. Kaptchuk TJ, Eisenberg DM (2001) Varieties of healing. 2: a taxonomy of unconventional healing practices. Ann Intern Med 135(3):196-204
28. Zollman C, Vickers A (1999) ABC of complementary medicine. Complementary medicine in conventional practice. BMJ 319(7214):901-904
29. Downer SM, Cody MM, McCluskey P et al (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309(6947):86-89